ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ZSAN

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2019/03/15	05:12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/03/15	05:05	Business Wire	Zosano Pharma Reports Fourth Quarter and Fiscal Year 2018 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/03/12	05:30	GlobeNewswire Inc.	Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/03/12	01:30	GlobeNewswire Inc.	Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/03/08	06:30	GlobeNewswire Inc.	Zosano Pharma to Host Conference Call on Fourth Quarter and Full Year 2018 Financial Results and Provide Operational and Stra...	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/03/01	07:58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/03/01	07:12	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/02/21	20:00	GlobeNewswire Inc.	Zosano Announces Completion of the Final Milestone in the Long-Term Safety Study of Qtrypta™ for the Acute Treatment of Mig...	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/02/15	07:28	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/01/31	22:30	GlobeNewswire Inc.	Zosano Announces Publication of Positive Data on Qtrypta’s™ Potential as an Acute Treatment for Patients with Difficult-t...	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/01/16	22:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/01/16	22:30	GlobeNewswire Inc.	Zosano Appoints Linda Grais M.D., J.D. to Board of Directors	NASDAQ:ZSAN	Zosano Pharma Corporation
2019/01/05	03:00	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/12/20	23:52	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/12/12	22:30	GlobeNewswire Inc.	Zosano Receives Conditional FDA Acceptance of Proposed Brand Name Qtrypta™ for M207	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/11/16	06:36	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/11/15	21:35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/11/15	06:23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/11/15	06:05	GlobeNewswire Inc.	Zosano Pharma Reports Third Quarter 2018 Financial Results and Operational Update	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/11/08	06:30	GlobeNewswire Inc.	Zosano Pharma to Host Conference Call on Third Quarter 2018 Financial Results and Provide Operational Update	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/23	21:30	GlobeNewswire Inc.	Zosano Treats over 4,000 Migraines and Reaches an Important Goal in M207-ADAM Long-term Safety Study	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/18	21:00	GlobeNewswire Inc.	Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients’ Perspective	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/17	05:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/17	05:46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/16	21:34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/16	21:30	GlobeNewswire Inc.	Zosano Appoints New Chief Financial Officer	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/03	21:33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/10/03	21:30	GlobeNewswire Inc.	Zosano Pharma Engages Contract Manufacturer as Part of the Commercialization Strategy for M207	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/09/26	21:34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2018/09/26	21:30	GlobeNewswire Inc.	Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment	NASDAQ:ZSAN	Zosano Pharma Corporation